• 1
    Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast project (Protocol No. 4) I. Observations concerning the multicentricity of mammary carcinoma. Cancer. 1975;35: 247254.
  • 2
    McDivitt RW. Breast cancer multicentricity. In: McDivittRW, ObermanHA, OzzelloL, KaufmanN, editors. The breast. Baltimore: Williams and Wilkins, 1984: 139.
  • 3
    Sarnelli R, Squartini F. Multicentricity in breast cancer: a submacroscopic study. Pathol Annu. 1986; 21(Part 1): 143–158.
  • 4
    Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole organ analysis and clinical implications. Br J Cancer. 1996; 74: 820824.
  • 5
    Fowble B, Yeh I, Schultz DJ, et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys. 1993; 27: 567573.
  • 6
    Anastassiades O, Iokovou E, Stavridou N, Gogas J, Karameris A. Multicentricity in breast cancer a study of 366 cases. Am J Clin Pathol. 1993; 99: 238243.
  • 7
    Spinelli C, Berti P, Ricci E, Miccoli P. Multicentric breast tumor: an anatomical-clinical study of 100 cases. Eur J Surg Oncol. 1992; 18: 2326.
  • 8
    Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10 year survival. Cancer. 1982; 49: 11231130.
  • 9
    Cheatle GL, Culter M. Tumors of the breast: their pathology, symptoms, diagnosis and treatment. Philadelphia: J.B. Lippincott, 1931: 1.
  • 10
    Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol Annu. 1981; 16(Part 2): 83102.
  • 11
    Breast cancer. In: FlemmingID, CooperJS, HensonDE, et al. American Joint Committee on Cancer. Cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven Publishers, 1997: 172173.
  • 12
    Vlastos G, Rubio I, Mirza NQ, et al. The impact of multicentricity on clinical outcome in patients with T1-2, N0-1, MO) breast cancer. Ann Surg Oncol. 2000; 180: 252256.
  • 13
    Black MM, Speer FD. Nuclear structures in cancer tissues. Surg Gynecol Obstet. 1957; 105: 97102.
  • 14
    Cutler SJ, Black MM, Mark T, Harvei S, Freeman C. Further observations on prognostic factors in cancer of the female breast. Cancer. 1969; 24: 653667.
  • 15
    Hsu SM, Raine L, Fanger H. Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem. 1981; 29: 577580.
  • 16
    Kemp BL. Breast specimen evaluation. In: SingletarySE, editor. Breast cancer. M. D. Anderson Solid Tumor Oncology Series. New York: Springer-Verlag, 1999: 120131.
  • 17
    Gallager HS, Martin JE. The study of mammary carcinoma by correlated mammography and subserial whole organ sectioning: early observations. Cancer. 1969; 23: 855873.
  • 18
    Lesser ML, Lesser PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982; 19(2): 234240.
  • 19
    Seine RT, Rosen PP, Lesser ML, et al. Epidemiology of breast carcinoma II. Factors related to the predominance of left-sided disease. Cancer. 1980;46: 17051713.
  • 20
    Luttges J, Kalbfleisch H, Prinz P. Nipple involvement and multicentricity in breast cancer. J Cancer Res Clin Oncol. 1987; 113: 481487.
  • 21
    Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995; 26: 965969.